Back to search
Langerhans Cell Histiocytosis of Bone
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Langerhans Cell Histiocytosis of Bone trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Langerhans Cell Histiocytosis of Bone trials you may qualify forThis study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patient…
The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understandin…
Langerhans cell histiocytosis (LCH) is the most common type of histiocytic disorder in children, affecting about 2.6 to 8.9 out of every million kids each year.…
This is a data collection study that will examine the general diagnostic and treatment data associated with the reduced-intensity chemotherapy-based regimen pai…
The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double…
This phase I trial tests the safety, side effects, and best dose of Q702 in treating patients with hematologic malignancies. Q702 is in a class of medications c…
This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have recurred or spread to other places in the…
This phase II Pediatric MATCH trial studies how well ivosidenib works in treating patients with solid tumors, including central nervous system tumors, lymphomas…